Patent Number: 8,796,423

Title: Anti-TSG101 antibodies and their uses for treatment of viral infections

Abstract: The present invention provides antibodies that bind to the C-terminal region of TSG101. The invention also provides methods of using the TSG101 antibodies for the treatment of viral infections, including HIV and Ebola virus infection.

Inventors: Li; Limin (North Bethesda, MD), Kinch; Michael (Laytonsville, MD), Goldbiatt; Michael (McLean, VA)

Assignee: Eli Lilly and Company

International Classification: C12Q 1/70 (20060101); C07K 16/00 (20060101)

Expiration Date: 8/05/12018